Submissions

About the Journal

Galen Medical Journal (GMJ) is an official journal of  Noncommunicable Diseases (NCD) Research Center of  Fasa University of Medical Sciences. The GMJ established in 2012 and is an international, peer-reviewed, open access publication. The GMJ is available both in print and online. GMJ published quarterly in English by  Noncommunicable Diseases (NCD) Research Center of  Fasa University of Medical Sciences and is a peer-reviewed general medical journal for all physicians, doctors, medical researchers, and health workers. The journal allows free access (Open Access) to its contents and permits authors to the self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.

Scope of The Journal

The journal will cover basic and clinical studies in the field of all medicine, especially Non-communicable Diseases. Articles with clinical interest and implications will be given preference.

Overall Conditions for Submission

The manuscript should be prepared according to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (International Committee of Medical Journal Editors) and must comply with the ethical standards recommended by the Helsinki Declaration. 

GMJ complies with the International Committee of Medical Journal Editors (ICMJE) recommendations.

www.icmje.org/recommendations/ 

please, read these recommendations before submission

The Editorial Process

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to GMJ alone then and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere.

The journal expects that authors would authorize one of them to correspond with GMJ for all matters related to the manuscript. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the GMJ readers are also liable to be _rejected at this stage itself.

Manuscripts that are found suitable for publication in GMJ are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.

Manuscripts accepted for publication are copyedited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author.

The corresponding author is expected to return the corrected proofs within seven days. It may not be possible to incorporate corrections received after that period.

The whole process of submission of the manuscript to the final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ soon after acceptance.

Clinical Trial Registry

The GMJ would consider publishing clinical trials that have been registered with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable:

http://www.irct.ir

http://www.clinicaltrials.gov

http://www.trialregister.nl

http://www.umin.ac.jp

Also, any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/network/primary/en/index.html).

Authorship Criteria

 As stated in the International Committee of Medical Journal Editors (ICMJE) Recommendations, credit for authorship requires:

1. Substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data,

2. The drafting of the article or critical revision for important intellectual content;

3. Final approval of the version to be published;

4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.

Authorship credit should be based only on substantial contributions to each of the four components mentioned above.

Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript.

The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors.

GMJ Authorship Standards

 To respect the authorship right of authors and uphold scientific honesty, the authorship of GMJ should be compiled as follows:

1- Author names should not be added, removed and changed the order after submitted the manuscript.

2- Each article could have one corresponding author. 

3- Authors are not recommended to be co-first authors. Authors in the same institution could not be the co-first authors. 

The GMJ reserves the right of final explanations to the Authorship standard. 

Contribution Details

Contributors should provide a description of contributions made by each of them towards the manuscript.

The description should be divided into following categories, as applicable: concept, design, the definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review. One author should take responsibility for the integrity of the work as a whole from inception to published article and should be